UW-HTK study | EC-HTK study | |||
---|---|---|---|---|
EC-HTK study | HTK (n=314) | UW (n=297) | HTK (n=292) | EC (n=277) |
1 year | 83% | 81% | 80% | 78% |
2 year | 77% | 73% | 76% | 71% |
3 year | 73% | 68% | 70% | 68% |
INF | 33% | 33% | 29% | 43% |
n = number of transplants
INF = Initial non-function was defined as the absence of life-sustaining renal function, requiring dialysis treatment on two or more occasions, during the first week after transplantation.
1) de Boer J, De Meester J, Smits JM, Groenewoud AF, Bok A, van der Velde O, Doxiadis II, Persijn GG. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int. 1999;12(6):447-53
Acute kidney injury | CUSTODIOL (n=42) | Ringer’s group (n=42) |
---|---|---|
No AKI | 38.1% | 9.5% |
AKI type 1 | 35.7% | 50% |
AKI type 2 | 9.5% | 21.4% |
AKI type 3 | 16.7% | 19.0% |
Acute kidney injury (AKI) was defined by Kidney Disease Improving Global Outcomes guidelines discharge. Freedom from AKI was significantly increased in the CUSTODIOL group vs the group treated with cold lactated Ringer’s solution despite longer total renal ischemic time (51.5 minutes vs 43.6 minutes). Furthermore, CUSTODIOL does not require any implementation of the solution with osmotic agents and prednisolone.
2) Tshomba Y, Kahlberg A, Melissano G, Coppi G, Marone E, Ferrari D, Lembo R, Chiesa R. Comparison of renal perfusion solutions during thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2014 Mar;59(3):623-33